切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2018, Vol. 12 ›› Issue (01) : 35 -38. doi: 10.3877/cma.j.issn.1674-3946.2018.01.012

所属专题: 经典病例 文献

论著

腹腔镜侧方淋巴结清扫术治疗中低位直肠癌48例疗效分析
郭校锡1,(), 邓建中1, 林义办1, 李朝阳1, 梁姗姗1, 冯结兰1, 伍巧玲1   
  1. 1. 528000 广东佛山市第一人民医院
  • 收稿日期:2017-11-08 出版日期:2018-02-26
  • 通信作者: 郭校锡

Clinical analysis of laparoscopic lateral lymph node dissection in the treatment of mid-low rectal cancer

Xiaoxi Guo1,(), Jianzhong Deng1, Yiban Lin1, Zhaoyang Li1, Shanshan Liang1, Jielan Feng1, Qiaoling Wu1   

  1. 1. The First People Hospital of Foshan, Guangdong 528000, China
  • Received:2017-11-08 Published:2018-02-26
  • Corresponding author: Xiaoxi Guo
  • About author:
    Corresponding author: Guo Xiaoxi, Email:
引用本文:

郭校锡, 邓建中, 林义办, 李朝阳, 梁姗姗, 冯结兰, 伍巧玲. 腹腔镜侧方淋巴结清扫术治疗中低位直肠癌48例疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2018, 12(01): 35-38.

Xiaoxi Guo, Jianzhong Deng, Yiban Lin, Zhaoyang Li, Shanshan Liang, Jielan Feng, Qiaoling Wu. Clinical analysis of laparoscopic lateral lymph node dissection in the treatment of mid-low rectal cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2018, 12(01): 35-38.

目的

评估保留自主神经的腹腔镜侧方淋巴结清扫术在治疗中低位直肠癌的疗效。

方法

回顾分析2011年6月至2016年12月接受腹腔镜侧方淋巴结清扫手术的48例直肠癌患者的临床资料,记录患者的手术相关情况、术后功能恢复情况及影响侧方淋巴结转移的肿瘤病理学因素,分析患者的预后情况并作统计学分析。数据采用SPSS 19. 0统计软件包分析,术中术后计量资料用均数±标准差表示,采用t检验;患者的临床特点及病理因素与侧方淋巴结转移的关系,采用χ2检验,P<0.05表示差异具有统计学意义。

结果

手术时间为(245.7±46.7) min,术中出血量为(223.7±66.0) ml,平均住院时间(8.3±1.4) d、术后排气时间(3.8±0.8) d。13例(27.1%)患者出现短暂轻—中度排尿功能障碍,23例(47.9%)出现性功能障碍。41例患者发生周围淋巴结转移,15例(31.3%)侧方淋巴结转移;共清扫出648枚淋巴结,阳性304枚,侧方淋巴结转移33枚(5.1%),转移率与侧方淋巴结直径、病理类型及TNM分期相关。随访40个月,36例患者术后生存,15例局部复发,12例死亡;3例患者带瘤生存,33例无瘤生存;有侧方淋巴结转移组患者的预后比无侧方转移患者差。

结论

腹腔镜侧方淋巴结清扫术治疗中低位直肠癌中是安全、可行的,可有效改善预后;保留自主神经能有效保护性功能、排尿功能。

Objective

To evaluate the efficacy of laparoscopic lateral lymph node dissection with the preservation of the autonomic nerve in the treatment of middle and low rectal cancer.

Methods

The clinical data of 48 patients with rectal cancer who underwent laparoscopic lateral lymph node dissection from June 2011 to December 2016 were retrospectively analyzed. The operation, postoperative recovery and prognosis were recorded. The prognosis of the patients was analyzed. The data were analyzed by SPSS 19.0 statistical software package. The postoperative measurement data were expressed with mean standard deviation and by t test. The relationship between clinical characteristics and pathological factors and lateral lymph node metastasis was analyzed by chi square test. P<0.05 indicated that the difference was statistically significant.

Results

The operating time was (245.7±46.7) min, and mean blood loss was (223.7±66.0) ml. The average hospital stay time and exhaust time were (8.3±1.4) days and (3.8±0.8) days respectively. 13(27.1%) cases were suffered from transient mild-moderate urinary dysfunction, and 23 (47.9%) cases were developed sexual dysfunction. Of the 48 patients, lymph node metastasis was found in 41 patients, and lateral lymph node metastasis was found in 15 cases. A total of 648 lymph nodes were cleared, in which 304 mesenteric lymph nodes and 33(5.1%) lateral lymph node were positive. The lateral lymph node metastasis was related to the diameter of lateral lymph node, the pathological type and the TNM stage of the tumor. Followed-up 40 months, a total of 36 cases survived, 15 cases developed local recurrence, 12 cases died from metastasis, 3 cases lived with tumor, and 33 cases were disease-free survival. The patients with lateral lymph node metastasis and the group of positive lateral lymph node had a poor prognosis than the other patients.

Conclusion

Laparoscopic lateral lymph node dissection for patients with mid-low rectal cancer is safe and feasible, and it can improve the prognosis. Autonomic nerve-preserving surgery can effectively protect sexual function and urinary function.

表1 48例中低位直肠癌患者行根治性切除+侧方淋巴清扫病理因素对侧方淋巴结的影响
表2 48例中低位直肠癌患者行侧方淋巴清扫后有无侧方淋巴结转移对预后的影响[例(%)]
表3 48例中低位直肠癌患者新辅助治疗后侧方淋巴结大小对预后的影响
[1]
王自强,周总光.腹腔镜低位直肠癌经腹会阴联合切除并侧方淋巴结清扫术[J/CD].中华普外科手术学杂志:电子版,2015,9(3).
[2]
Moriya Y. Treatment of lateral pelvic nodes metastases from rectal cancer: the future prospective[J]. G Chir,2013,34(9-10):245-248.
[3]
Watanabe T, Muro K, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer[J]. Int J Clin Oncol,2017, 27. doi:10.1007/s10147-017-1101-6.
[4]
Yagi R, Shimada Y, Kameyama H, et al. Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer: A Retrospective Study at Two Institutions[J]. Ann Surg Oncol,2016,23(Suppl 4):552-558.
[5]
Hasegawa S, Takahashi R, Hida K, et al. Revisiting the treatment strategy for?rectal cancer?through the pattern of local recurrence[J]. Eur J Surg Oncol, 2016,42(11):1674-1679.
[6]
Homma Y, Hamano T, Otsuki Y, et al. Total number of lymph node metastases is a more significant risk factor for poor prognosis than positive lateral lymph node metastasis[J]. Surg Today, 2015, 45(2):168-174.
[7]
Kinugasa T, Akagi Y, Shirouzu K. Benefit of lateral lymph node dissection for rectal cancer: long-term analysis of 944 cases undergoing surgery at a single center (1975-2004) [J]. Anticancer Res,2014,34(8):4633-4639.
[8]
Oh HK, Kang SB, Lee SM, et al. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study[J]. Ann Surg Oncol,2014,21(7):2280-2287.
[9]
Nagayoshi K, Ueki T, Manabe T, et al. Laparoscopic lateral pelvic lymph node dissection is achievable and offers advantages as a minimally invasive surgery over the open approach[J]. Surg Endosc, 2016,30(5):1938-1947.
[10]
Ogura A, Akiyoshi T, Nagasaki T, et al. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy[J]. World J Surg, 2017, 41(3):868-875.
[11]
Yamaguchi T, Kinugasa Y, Shiomi A, et al. Robotic-assisted vs. conventional laparoscopic surgery for rectal cancer: short-term outcomes at a single center[J]. Surg Today, 2016, 46(8):957-962.
[12]
Yamaguchi T, Kinugasa Y, Shiomi A, et al. Robotic-assisted laparoscopic versus open lateral lymph node dissection for advanced lowerrectal cancer[J]. Surg Endosc,2016,30(2):721-728.
[13]
Fujita S, Mizusawa J, Kanemitsu Y, et al. Mesorectal Excision With or Without Lateral Lymph NodeDissection for Clinical Stage Ⅱ/Ⅲ Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial[J]. Ann Surg,2017,266(2):201-207.
[14]
Nagasaki T, Akiyoshi T, Fujimoto Y, et al. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases[J]. World J Surg,2017,41(3):876-883.
[15]
Oh HK, Kang SB, Lee SM, et al. Neoadjuvantchemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study[J]. Ann SurgOncol. 2014,21(7):2280-2287.
[16]
Yamaoka Y, Kinugasa Y, Shiomi A, et al. Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer[J]. Int J Colorectal Dis, 2017,32(11):1631-1637.
[17]
Inoue Y, Saigusa S, Hiro J, et al. Clinical significance of enlarged lateral pelvic lymph nodes before and after preoperative chemoradiotherapy for rectal cancer[J]. Mol Clin Oncol, 2016 ,4(6):994-1002.
[18]
Kim MJ, Kim TH, Kim DY, et al. Can chemoradiation allow foromission of lateral pelvic node dissection for locally advanced rectal cancer[J]? J SurgOncol,2015,111(4):459-464.
[19]
Saito S, Fujita S, Mizusawa J, et al. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212[J]. Eur J Surg Oncol,2016,42(12):1851-1858.
[1] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[2] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[5] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[8] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[9] 郑民华, 蒋天宇, 赵轩, 马君俊. 中国腹腔镜直肠癌根治术30年发展历程与未来[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 591-595.
[10] 池畔, 黄胜辉. 中国腹腔镜直肠癌根治术30年来的巨大进步[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 596-600.
[11] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[12] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[13] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
[14] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[15] 王灿, 樊昊, 张卫, 于冠宇. LARS 评分的研制回顾与应用现状[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 519-523.
阅读次数
全文


摘要